HUM vs TRAW · P/E 39, rev $117.76B vs rev $226.0K
Humana Inc (HUM) versus Traws Pharma Inc (TRAW) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported TRAW revenue for 2024-12-31 was $226.0K. Net income was -$166.5M. Revenue was up 0.0% from 2023-12-31 to 2024-12-31. TRAW currently screens at market cap $12.1M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. TRAW currently screens at market cap $12.1M.
Not investment advice. Open the HUM and TRAW stock pages for the full models.
Not investment advice.